These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 16544042

  • 21. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
    Pezzuti IL, Barra CB, Mantovani RM, Januário JN, Silva IN.
    J Pediatr (Rio J); 2014; 90(3):300-7. PubMed ID: 24560529
    [Abstract] [Full Text] [Related]

  • 22. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome.
    Maffazioli GDN, Bachega TASS, Hayashida SAY, Gomes LG, Valassi HPL, Marcondes JAM, Mendonca BB, Baracat EC, Maciel GAR.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32530459
    [Abstract] [Full Text] [Related]

  • 23. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS, Allen DB, Hoffman GL.
    J Pediatr; 2005 Oct 01; 147(4):493-8. PubMed ID: 16227036
    [Abstract] [Full Text] [Related]

  • 24. Severe adrenal insufficiency in six neonates with normal newborn screening for CAH.
    Kurt I, Eser M, Kahveci A, Ucar A, Bulus D, Ozcabi B, Guran O, Karagozlu S, Ersoy A, Demir S, Geckinli B, Guran T.
    Clin Endocrinol (Oxf); 2024 Aug 01; 101(2):108-113. PubMed ID: 38796770
    [Abstract] [Full Text] [Related]

  • 25. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group.
    Eur J Endocrinol; 2005 Jun 01; 152(6):869-74. PubMed ID: 15941926
    [Abstract] [Full Text] [Related]

  • 26. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
    Oriolo C, Fanelli F, Castelli S, Mezzullo M, Altieri P, Corzani F, Pelusi C, Repaci A, Di Dalmazi G, Vicennati V, Baldazzi L, Menabò S, Dormi A, Nardi E, Brillanti G, Pasquali R, Pagotto U, Gambineri A.
    J Endocrinol Invest; 2020 Oct 01; 43(10):1499-1509. PubMed ID: 32236851
    [Abstract] [Full Text] [Related]

  • 27. Serum 17 alpha hydroxyprogesterone in normal full term and preterm vs sick preterm and full term newborns in a tertiary hospital.
    Chennuri VS, Mithbawkar SM, Mokal RA, Desai MP.
    Indian J Pediatr; 2013 Jan 01; 80(1):21-5. PubMed ID: 22865354
    [Abstract] [Full Text] [Related]

  • 28. Neonatal screening for congenital adrenal hyperplasia.
    van der Kamp HJ, Wit JM.
    Eur J Endocrinol; 2004 Nov 01; 151 Suppl 3():U71-5. PubMed ID: 15554889
    [Abstract] [Full Text] [Related]

  • 29. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.
    van der Kamp HJ, Oudshoorn CG, Elvers BH, van Baarle M, Otten BJ, Wit JM, Verkerk PH.
    J Clin Endocrinol Metab; 2005 Jul 01; 90(7):3904-7. PubMed ID: 15797960
    [Abstract] [Full Text] [Related]

  • 30. Congenital adrenal hyperplasia: issues in diagnosis and treatment in children.
    Sharma R, Seth A.
    Indian J Pediatr; 2014 Feb 01; 81(2):178-85. PubMed ID: 24254335
    [Abstract] [Full Text] [Related]

  • 31. 21-Deoxycortisol is a Key Screening Marker for 21-Hydroxylase Deficiency.
    Held PK, Bialk ER, Lasarev MR, Allen DB.
    J Pediatr; 2022 Mar 01; 242():213-219.e1. PubMed ID: 34780778
    [Abstract] [Full Text] [Related]

  • 32. Rapid monitoring assay of congenital adrenal hyperplasia with microbore high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots.
    Lai CC, Tsai CH, Tsai FJ, Lee CC, Lin WD.
    Rapid Commun Mass Spectrom; 2001 Mar 01; 15(22):2145-51. PubMed ID: 11746879
    [Abstract] [Full Text] [Related]

  • 33. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.
    Pediatrics; 1996 Sep 01; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [Abstract] [Full Text] [Related]

  • 34. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb 01; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 35. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
    Tieh PY, Yee JK, Hicks RA, Mao CS, Lee WN.
    J Perinatol; 2017 Mar 01; 37(3):283-287. PubMed ID: 27929529
    [Abstract] [Full Text] [Related]

  • 36. Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency.
    Turcu AF, Rege J, Chomic R, Liu J, Nishimoto HK, Else T, Moraitis AG, Palapattu GS, Rainey WE, Auchus RJ.
    J Clin Endocrinol Metab; 2015 Jun 01; 100(6):2283-90. PubMed ID: 25850025
    [Abstract] [Full Text] [Related]

  • 37. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
    Gong LF, Gao X, Yang N, Zhao JQ, Yang HH, Kong YY.
    J Pediatr Endocrinol Metab; 2019 Mar 26; 32(3):253-258. PubMed ID: 30817302
    [Abstract] [Full Text] [Related]

  • 38. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
    Thil'en A, Nordenström A, Hagenfeldt L, von Döbeln U, Guthenberg C, Larsson A.
    Pediatrics; 1998 Apr 26; 101(4):E11. PubMed ID: 9521977
    [Abstract] [Full Text] [Related]

  • 39. Measurement of Serum 17α-Hydroxyprogesterone in Infants by Radioimmunoassay.
    Muñoz LN, Ochetti M, Perez G, Sobrero GM, Silvano LK, Martin SE, Testa GM, Miras MB.
    Pediatr Endocrinol Rev; 2015 Jun 26; 12(4):366-72. PubMed ID: 26182481
    [Abstract] [Full Text] [Related]

  • 40. Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points.
    Eshragh N, Doan LV, Connelly KJ, Denniston S, Willis S, LaFranchi SH.
    Horm Res Paediatr; 2020 Jun 26; 93(2):128-136. PubMed ID: 32659761
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.